110 related articles for article (PubMed ID: 37949284)
21. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo.
Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K
J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel/IR1061-Co-Loaded Protein Nanoparticle for Tumor-Targeted and pH/NIR-II-Triggered Synergistic Photothermal-Chemotherapy.
He L; Qing F; Li M; Lan D
Int J Nanomedicine; 2020; 15():2337-2349. PubMed ID: 32308385
[TBL] [Abstract][Full Text] [Related]
23. Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models.
Foglietta F; Spagnoli GC; Muraro MG; Ballestri M; Guerrini A; Ferroni C; Aluigi A; Sotgiu G; Varchi G
Int J Nanomedicine; 2018; 13():4847-4867. PubMed ID: 30214193
[TBL] [Abstract][Full Text] [Related]
24. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
25. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
26. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Biological Activity of Folic Acid-Modified Paclitaxel-Loaded Gold Nanoparticles.
Ren B; Cai ZC; Zhao XJ; Li LS; Zhao MX
Int J Nanomedicine; 2021; 16():7023-7033. PubMed ID: 34703225
[TBL] [Abstract][Full Text] [Related]
28. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
29. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
30. Gallic acid sensitizes paclitaxel-resistant human ovarian carcinoma cells through an increase in reactive oxygen species and subsequent downregulation of ERK activation.
Sánchez-Carranza JN; Díaz JF; Redondo-Horcajo M; Barasoain I; Alvarez L; Lastres P; Romero-Estrada A; Aller P; González-Maya L
Oncol Rep; 2018 Jun; 39(6):3007-3014. PubMed ID: 29693189
[TBL] [Abstract][Full Text] [Related]
31. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability.
Zhao J; Du J; Wang J; An N; Zhou K; Hu X; Dong Z; Liu Y
ACS Appl Mater Interfaces; 2021 Mar; 13(12):14577-14586. PubMed ID: 33728919
[TBL] [Abstract][Full Text] [Related]
32. Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.
Chowdhury P; Nagesh PKB; Hatami E; Wagh S; Dan N; Tripathi MK; Khan S; Hafeez BB; Meibohm B; Chauhan SC; Jaggi M; Yallapu MM
J Colloid Interface Sci; 2019 Feb; 535():133-148. PubMed ID: 30292104
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anti-cancer evaluation of folic acid-peptide- paclitaxel conjugates for addressing drug resistance.
Dai Y; Cai X; Bi X; Liu C; Yue N; Zhu Y; Zhou J; Fu M; Huang W; Qian H
Eur J Med Chem; 2019 Jun; 171():104-115. PubMed ID: 30913525
[TBL] [Abstract][Full Text] [Related]
34. Effect of targeting ligand designation of self-assembly chitosan-poloxamer nanogels loaded Paclitacel on inhibiting MCF-7 cancer cell growth.
Nguyen VT; Doan P; Nguyen DT; Doan VD; Dao TP; Plavskii V; Nguyen BT; Tran NQ
J Biomater Sci Polym Ed; 2022 Mar; 33(4):426-442. PubMed ID: 34641768
[TBL] [Abstract][Full Text] [Related]
35. Targeted delivery of paclitaxel drug using polymer-coated magnetic nanoparticles for fibrosarcoma therapy: in vitro and in vivo studies.
Al-Obaidy R; Haider AJ; Al-Musawi S; Arsad N
Sci Rep; 2023 Feb; 13(1):3180. PubMed ID: 36823237
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone simulates the anticancer effect of nano-formulated paclitaxel in breast cancer cells.
Diab T; AlKafaas SS; Shalaby TI; Hessien M
Bioorg Chem; 2020 Jun; 99():103792. PubMed ID: 32240873
[TBL] [Abstract][Full Text] [Related]
37. Folic acid functionalized starch encapsulated green synthesized copper oxide nanoparticles for targeted drug delivery in breast cancer therapy.
Mariadoss AVA; Saravanakumar K; Sathiyaseelan A; Venkatachalam K; Wang MH
Int J Biol Macromol; 2020 Dec; 164():2073-2084. PubMed ID: 32784027
[TBL] [Abstract][Full Text] [Related]
38. l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells.
Niu S; Bremner DH; Wu J; Wu J; Wang H; Li H; Qian Q; Zheng H; Zhu L
Drug Deliv; 2018 Nov; 25(1):1275-1288. PubMed ID: 29847177
[TBL] [Abstract][Full Text] [Related]
39. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells.
Diab T; Alkafaas SS; Shalaby TI; Hessien M
Anticancer Agents Med Chem; 2020; 20(13):1582-1591. PubMed ID: 32364081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]